BowTiedBiotech

BowTiedBiotech

The Assets Pharma Actually Wants | Ep. 962

Why legible therapeutics now command the premium

Mar 19, 2026
∙ Paid

Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary, as always on Thursday, focuses on the general market update. For the week the XBI was down -.025% and now sits at +0.3% year-to-date. This week the market clarified the rules. Biotech can rally and capital can return quickly, but funding is flowing to companies with clean cat…

User's avatar

Continue reading this post for free, courtesy of BowTiedBiotech.

Or purchase a paid subscription.
© 2026 BowTiedBiotech · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture